ClinicalTrials.gg
CompletedNCT02972749Updated Jan 3, 2018

Modifiable Factors and Glaucoma - RCT

An interventional study of Intervention in Intraocular Pressure, sponsored by Wolfson Medical Center. Completed at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-01-03.

Sponsored by Wolfson Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

There is growing awareness that environmental factors, behaviors and diet are intimately related to patient health and may play a role in the pathogenesis and progression of glaucoma. Evidence from recent years has shown that some behaviors and environmental factors can affect the intraocular pressure, the primary risk factor for glaucoma. This study aims to investigate whether simple and common lifestyle inteventions such as sleeping with a head elevation, a high fiber diet, moderate aerobic exercise and moderation in caffeine intake could affect intraocular pressure and other outcomes.

02

Conditions studied

  • Intraocular Pressure
03

In context

Lead sponsor

Wolfson Medical Center is the lead sponsor of 118 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with glaucoma.

Exclusion criteria

Exclusion Criteria:

  • Not able to attend follow-up
  • Contraindication for treatment or follow-up
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Intervention

    Recommendations for lifestyle changes which have shown to reduce IOP. recommendations include: Moderate aerobic exercise, High fiber diet, sleeping with a head elevation and moderating caffeine intake. while continuing prescribed medical therapy.

    Behavioral: Intervention

  • No intervention
    Control

    No intervention. patients are instructed to continue prescribed medical therapy.

Interventions

  • BehavioralIntervention

    Recommendations for lifestyle changes which have shown to reduce IOP. recommendations include: Moderate aerobic exercise, High fiber diet, sleeping with a head elevation and moderating caffeine intake. while continuing prescribed medical therapy.

06

What researchers measure

Primary outcomes

  1. Intraocular pressure

    Time frame: Following 1 month of treatment

Secondary outcomes

  1. Illness perception questionnaire results

    Time frame: Following 1 month of treatment

07

Study locations

1 site
  • The E.Wolfson Medical Center
    Holon, 58100, Israel
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2016 to primary completion in Dec 2017, 13 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2016
First posted
Nov 23, 2016
StartActual
Nov 2016
Primary completionActual
Dec 2017
CompletionActual
Dec 2017
Last update
Jan 3, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 3, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02972749
Responsible party
Sponsor
First posted
Nov 23, 2016
Start date
Nov 2016
Primary completion
Dec 2017
Completion
Dec 2017
Last update
Jan 3, 2018

Study contacts

Asaf Achiron, MD
principal investigator · Wolfson Medical Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion